BR0116293A - Composição tópica, e, método para prevenir, melhorar ou tratar a hiperpigmentação da pele - Google Patents

Composição tópica, e, método para prevenir, melhorar ou tratar a hiperpigmentação da pele

Info

Publication number
BR0116293A
BR0116293A BR0116293-4A BR0116293A BR0116293A BR 0116293 A BR0116293 A BR 0116293A BR 0116293 A BR0116293 A BR 0116293A BR 0116293 A BR0116293 A BR 0116293A
Authority
BR
Brazil
Prior art keywords
preventing
ameliorating
hyperpigmentation
topical composition
skin
Prior art date
Application number
BR0116293-4A
Other languages
English (en)
Other versions
BRPI0116293B1 (pt
Inventor
Dmitri Ptchelintsev
Christos D Kyrou
Harish Mahalingam
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of BR0116293A publication Critical patent/BR0116293A/pt
Publication of BRPI0116293B1 publication Critical patent/BRPI0116293B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçãO TóPICA E MéTODO PARA PREVENIR MELHORAR OU TRATAR A HIPERPIGMENTAçãO DA PELE". é provida uma composição tópica para tratar, prevenir ou melhorar hiperpigmentação em pele humana. A composição tem um agente de despigmentação em uma quantidade eficaz de reduzir ou diminuir a pigmentação em uma área da pele para a qual é aplicado, e um veículo farmaceuticamente ou cosmeticamente aceitável. Agentes de despigmentação adequados incluem ácido 3,3<39>-tiodipropiónico, acido tiazolidina-2-carboxílico, kaempferol-7-glucosídeo, óleo de perila, e clofibrato e clofibrato análogos e derivados. São providos métodos para tratar, prevenir ou melhorar a hiperpigmentação na pele humana.
BRPI0116293A 2000-12-20 2001-12-14 composição tópica para prevenir, melhorar ou tratar a hiperpigmentação da pele BRPI0116293B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/741,383 US6562321B2 (en) 2000-12-20 2000-12-20 Compositions and methods for treating hyperpigmentation
PCT/US2001/048382 WO2002049580A1 (en) 2000-12-20 2001-12-14 Compositions and methods for treating hyperpigmentation

Publications (2)

Publication Number Publication Date
BR0116293A true BR0116293A (pt) 2004-08-17
BRPI0116293B1 BRPI0116293B1 (pt) 2016-07-12

Family

ID=24980507

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0116293A BRPI0116293B1 (pt) 2000-12-20 2001-12-14 composição tópica para prevenir, melhorar ou tratar a hiperpigmentação da pele

Country Status (9)

Country Link
US (1) US6562321B2 (pt)
EP (1) EP1351647B1 (pt)
JP (1) JP2004516259A (pt)
CN (1) CN1274291C (pt)
AU (1) AU2002236626A1 (pt)
BR (1) BRPI0116293B1 (pt)
CA (1) CA2429935C (pt)
MX (1) MX246293B (pt)
WO (1) WO2002049580A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) * 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation
US20040067245A1 (en) * 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
US20040126351A1 (en) * 2002-12-26 2004-07-01 Avon Products, Inc. Topical composition having natural skin anti-irritant ingredient and method of use
US20040242501A1 (en) * 2003-03-20 2004-12-02 Gross Richard A. Spermicidal and virucidal properties of various forms of sophorolipids
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
US7429391B2 (en) * 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20090092561A1 (en) * 2007-10-09 2009-04-09 Lupia Joseph A Body-care and household products and compositions comprising specific sulfur-containing compounds
FR2928835B1 (fr) * 2008-03-20 2010-05-07 Nuxe Lab Composition depigmentante a base de crocus sativus.
PL2473183T3 (pl) * 2009-08-31 2018-11-30 Avon Products, Inc. Kosmetyczne zastosowania zmodyfikowanych ekstraktów drożdżowych i powiązanych kompozycji
EP2521558A4 (en) * 2009-12-30 2013-07-03 Avon Prod Inc TOPICAL LIGHTING COMPOSITION AND USES THEREOF
CN102078486B (zh) * 2011-01-21 2012-06-20 吉林紫鑫药物研究有限公司 一种祛黄褐斑的药物组合物及其制备方法
US9023327B2 (en) * 2012-08-30 2015-05-05 Avon Products, Inc. DICKKOPF-1 expression modulating compositions and uses thereof
EP2969030B1 (en) * 2013-03-12 2021-01-13 Avon Products, Inc. A topical lightening composition and methods of use thereof
CN106102838A (zh) * 2014-06-02 2016-11-09 雅芳产品公司 局部用增亮组合物及其使用方法
US11096881B2 (en) * 2016-05-29 2021-08-24 Scientis, SA Use of thiophosphate derivatives as skin depigmenting agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1000724A6 (fr) 1987-05-20 1989-03-21 Stiefel Lab Ltd Compositions a base de dithranol.
FR2639828B1 (fr) 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
JP2884466B2 (ja) * 1993-12-27 1999-04-19 長瀬産業株式会社 シソ抽出液、その製造方法およびそれを含有する美白化粧料
US6080393A (en) * 1994-07-09 2000-06-27 Johnson & Johnson Consumer Products, Inc. Skin care composition comprising a retinoid
FR2742750B1 (fr) 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
FR2773323B1 (fr) 1998-01-05 2000-02-11 Oreal Composition contenant une association de procysteine et de polyol
FR2778561B1 (fr) 1998-05-14 2001-04-20 Oreal Azurants optiques comme agents blanchissants
TW591026B (en) 1998-06-23 2004-06-11 Upjohn Co Inhibitors of alpha4beta1 mediated cell adhesion
DE19829789A1 (de) 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6087385A (en) * 1998-10-30 2000-07-11 University Of Mississippi Flavonoid derivatives
DE19929511C2 (de) * 1999-06-29 2003-04-10 Cognis Deutschland Gmbh Hochkonzentriert fließfähige Aniontensidmischungen
CA2413919A1 (en) * 2000-03-21 2001-09-13 Avon Products, Inc. Methods using phytol to improve the appearance of skin and compositions for such methods
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation

Also Published As

Publication number Publication date
MXPA03005510A (es) 2004-04-20
CA2429935A1 (en) 2002-06-27
BRPI0116293B1 (pt) 2016-07-12
EP1351647A1 (en) 2003-10-15
MX246293B (es) 2007-06-08
US20020141953A1 (en) 2002-10-03
CN1274291C (zh) 2006-09-13
CA2429935C (en) 2011-03-15
CN1482892A (zh) 2004-03-17
AU2002236626A1 (en) 2002-07-01
JP2004516259A (ja) 2004-06-03
EP1351647B1 (en) 2012-11-14
US6562321B2 (en) 2003-05-13
EP1351647A4 (en) 2005-03-16
WO2002049580A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
BR0116293A (pt) Composição tópica, e, método para prevenir, melhorar ou tratar a hiperpigmentação da pele
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
BRPI0408062A (pt) regulação de tecido queratinoso de mamìferos usando composições com hexamidina
TW200505490A (en) Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
PT1146908E (pt) Formulacoes que contem nucleotidos de anti-sentido para conexinas
EP1439832A4 (en) METHOD FOR THE TREATMENT OF ACNE VULGARIS WITH AN AVERMECTIN COMPOUND
BR0014512A (pt) Tratamento tópico para infecções por estreptococos
ES2129013A1 (es) Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
WO2001028491A3 (en) Method and composition for the treatment of dermatologic diseases
AU1552500A (en) Agent and method for permanent waving
CA2221900A1 (en) Use of trospium chloride and 2-component system for the same
AU2003256301B2 (en) Hair and nail treatments using alkanolamines
BR9713576A (pt) Composição de barbear emétodo para prevenção de pesudofolliculitis barbae.
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
KR970703142A (ko) 신전성 선조를 치료하기 위해 알파 히드록시산을 도포시키는 방법(applying alpha hydroxy acids for striae distensae)
DE69717311T2 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
EP1194109A4 (en) TOPICAL FORMULATIONS CONTAINING AGENTS THAT PROMOTE SKIN PENETRATION AND THEIR USE
Bottomley et al. Treatment of closed comedones–Comparisons of fulguration with topical tretinoin and electrocautery with fulguration
BR0115215A (pt) Método para o tratamento de inflamações
CO4900082A1 (es) Composiciones cosmeticas para aplicacion topica en la piel y/o brillante de la piel, que contienen extracto de corteza de sauce.
GEP20043231B (en) Resorcinol Composition
CA2322745A1 (en) Method of treating neuroma pain
AU2002312382B2 (en) Topical treatments using alkanolamines

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/07/2016, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 6/00; A61K 7/00; A61K 7/42; A61K 31/74.

Ipc: A61K 8/37 (2006.01), A61K 8/46 (2006.01), A61K 8/4

Ipc: A61K 8/37 (2006.01), A61K 8/46 (2006.01), A61K 8/4